Form 8-K - Current report:
SEC Accession No. 0001564590-21-043726
Filing Date
2021-08-12
Accepted
2021-08-12 10:43:34
Documents
3
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ikna-8k_20210812.htm 8-K 32830
2 EX-99.1 ikna-ex991_24.htm EX-99.1 164948
3 GRAPHIC gyjqtazivhqp000001.jpg GRAPHIC 3116
  Complete submission text file 0001564590-21-043726.txt   203323
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 211165998
SIC: 2836 Biological Products, (No Diagnostic Substances)